homeostasis/metabolism
• following challenge with low-dose azoxymethane (AOM)-dextran sulfate sodium (DSS)-induced intestinal inflammation for 18 weeks, all mice develop colitis with macroscopic lesions in the middle to distal regions of the colon while 31% exhibit colorectal dysplasia characterized by loss of epithelial polarity, unlike wild-type controls which develop colitis, but not dysplasia or cancer
• however, unchallenged mice develop normally and show no gross morphological abnormalities under normal physiological conditions
|
neoplasm
• following challenge with low-dose azoxymethane (AOM)-dextran sulfate sodium (DSS)-induced intestinal inflammation for 18 weeks, all mice develop colitis with macroscopic lesions in the middle to distal regions of the colon while 31% exhibit colorectal dysplasia characterized by loss of epithelial polarity, unlike wild-type controls which develop colitis, but not dysplasia or cancer
• however, unchallenged mice develop normally and show no gross morphological abnormalities under normal physiological conditions
|
cellular
• after 18 weeks on the AOM-DSS protocol, mice show a significantly lower level of the pro-apoptotic protein Bax in colonic tissues, and significantly decreased rates of apoptosis by TUNEL staining of Swiss roll colons, relative to wild-type controls
|
• after 18 weeks on the AOM-DSS protocol, mice show a significantly higher proliferation rate in colonic tissues than wild-type controls
|